Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying circulating biomarkers for major depressive disorder

4 Aug 2023

Abstract excerpt

Objective: To date, the current diagnosis of major depressive disorder (MDD) still depends on clinical symptomatologic criteria, misdiagnosis and ineffective treatment are common. The study aimed to explore circulating biomarkers for MDD diagnosis. Methods: A high-throughput antibody array technology was utilized to detect 440 circulating cytokines in eight MDD patients and eight age-and gender-matched healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Stress Responses and Cortisol
Share to Treatment of Major Depression
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37599893
DOI: 10.3389/fpsyt.2023.1230246

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying circulating biomarkers for major depressive disorderPMID 37599893Read ↗

Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are all associated with neurotoxic immune networks and their intricate interactions with metabolic syndromeSemantic proximity Read ↗

Identification of Diagnostic Markers for Major Depressive Disorder Using Machine Learning MethodsSemantic proximity Read ↗

Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are all associated with neurotoxic immune networks and their intricate interactions with metabolic syndrome.Semantic proximity Read ↗

Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studiesSemantic proximity Read ↗

Peripheral Blood Mononuclear Cell Biomarkers for Major Depressive Disorder: A Transcriptomic ApproachSemantic proximity Read ↗

Ferroptosis-related genes as diagnostic markers for major depressive disorder and their correlations with immune infiltrationSemantic proximity Read ↗

Dissection of the clinical phenome of major depressive disorder into subdomains and subgroups in relation to activated immune-inflammatory profilesSemantic proximity Read ↗

Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP studySemantic proximity Read ↗

Dissecting depression symptoms: multi-omics clustering uncovers immune-related subgroups and cell-type specific dysregulationSemantic proximity Read ↗

A review of new insights into existing major depressive disorder biomarkersSemantic proximity Read ↗

Assessing 42 inflammatory markers in 321 control subjects and 887 major depressive disorder cases: BMI and other confounders and overall predictive ability for current depressionSemantic proximity Read ↗

Genetic association and drug target exploration of inflammation-related proteins with risk of major depressive disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.